BBHC (TRNX) 10-K 27 Mar 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 24, 2014	Jun. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'MAGNEGAS CORP	'	'
Entity Central Index Key	'0001353487	'	'
Amendment Flag	'false	'	'
Current Fiscal Year End Date	'--12-31	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Common Stock, Shares Outstanding	'	28,449,859	'
Entity Public Float	'	'	$41,770,000

Audited_Balance_Sheets

Audited Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current Assets	'	'
Cash	$216,523	$1,470,642
Accounts receivable, net of allowance for doubtful accounts of $83,069 and $61,792 , respectively	125,930	119,207
Inventory (including units for resale), at cost	1,710,066	961,984
Prepaid and other current assets	46,473	106,600
Total Current Assets	2,098,992	2,658,433
Property and equipment, net of accumulated depreciation of $661,744 and $448,302 , respectively	5,306,152	7,193,371
Deferred tax asset	0	0
Intangible assets, net of accumulated amortization of $248,446 and $199,978 , respectively	482,824	527,022
Investment in joint ventures	490,410	490,410
Security Deposits	8,568	2,151
Total Assets	8,386,946	10,871,387
Current Liabilities	'	'
Accounts payable	231,008	483,841
Accrued expenses	341,579	95,704
Deferred revenue and customer deposits	179,339	233,330
Total Current Liabilities	751,926	966,822
Stockholders' Equity	'	'
Preferred stock: $0.001 par; 10,000,000 authorized; 1,000,000 issued and outstanding, respectively	1,000	1,000
Common stock: $0.001 par; 90,000,000 authorized;23,259,109 and 20,042,616 issued and outstanding, respectively	23,259	20,043
Additional paid-in capital	26,163,522	22,284,841
Issued and unearned stock compensation	0	-13,333
Accumulated deficit	-18,552,761	-12,234,039
Total Stockholders' Equity	7,635,020	10,058,512
Total Liabilities and Stockholders' Equity	$8,386,946	$10,871,387

Audited_Balance_Sheets_Parenth

Audited Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Balance Sheets [Abstract]	'	'
Allowance for doubtful accounts	$83,069	$61,792
Accumulated depreciation	661,744	448,302
Accumulated amortization	$248,446	$199,978
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	1,000,000	1,000,000
Preferred stock, shares outstanding	1,000,000	1,000,000
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	90,000,000	90,000,000
Common stock, shares issued	23,259,109	20,042,616
Common stock, shares outstanding	23,259,109	20,042,616

Audited_Statements_of_Operatio

Audited Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Statements of Operations [Abstract]	'	'
Revenue	$988,986	$677,529
Direct Costs	548,478	545,737
Gross Profit	440,508	131,792
Operating Expenses:	'	'
Selling, General and Administration	3,718,461	3,803,033
Net loss on of settlement contracts and Revaluation of assets	622,103	0
Investor Relations	287,401	303,975
Stock-based compensation	1,465,888	2,053,090
Research and Development	179,559	200,225
Depreciation and Amortization	484,907	452,231
Total Operating Expenses	6,758,319	6,812,554
Operating Income (Loss)	-6,317,811	-6,680,762
Other Income and (Expense)	0	0
Interest income/(expense)	-913	320
Total Other Income (Expense)	-913	320
Net Income (Loss) before tax benefit	-6,318,724	-6,680,442
Provision for Income Taxes	'	-456,500
Net Income (Loss)	($6,318,724)	($7,136,942)
Basic	($0.29)	($0.32)
Diluted	($0.29)	($0.32)
Weighted average common shares:	'	'
Basic and Diluted	21,781,076	17,410,423

Audited_Statement_of_Changes_i

Audited Statement of Changes in Stockholders' Equity (USD $)	Total	Preferred	Common	Additional Paid in Capital	Unearned Stock Comp	Accumulated Deficit
Beginning Balance at Dec. 31, 2011	$5,224,915	$2	$15,439	$10,334,904	($28,333)	($5,097,097)
Beginning Balance, shares at Dec. 31, 2011	'	2,000	15,438,930	'	'	'
Compensation recognized under consult agreement, May 31, 2008	15,000	'	'	'	15,000	'
Issued per resolution	998	998	'	'	'	'
Issued per resolution, shares	'	998,000	'	'	'	'
Issued in exchange for services	989,324	'	334	988,990	'	'
Common stock issued for services, shares	'	'	334,220	'	'	'
Options issued	1,039,500	'	'	1,039,500	'	'
Options exercised for cash	262,375	'	89	262,286	'	'
Options exercised for cash, shares	'	'	88,887	'	'	'
Previous exercised	'	'	38	-38	'	'
Previous exercised, shares	'	'	37,500	'	'	'
Private placement	10,475,981	'	4,139	10,471,842	'	'
Private placement, shares	'	'	4,139,077	'	'	'
Offerings costs	-824,039	'	'	-824,039	'	'
Sale of shares for cash	11,400	'	4	11,396	'	'
Sale of shares for cash, shares	'	'	4,000	'	'	'
Net Income (Loss)	-7,136,942	'	'	'	'	-7,136,942
Balance at Dec. 31, 2012	10,058,512	1,000	20,043	22,284,841	-13,333	-12,234,039
Balance, shares at Dec. 31, 2012	'	1,000,000	20,042,614	'	'	'
Compensation recognized under consult agreement, May 31, 2008	13,333	'	'	'	13,333	'
Issued in exchange for services	1,496,303	'	395	1,495,908	'	'
Common stock issued for services, shares	'	'	394,606	'	'	'
Common shares issued:	2,511,575	'	2,821	2,508,754	'	'
Common shares issued: (Shares)	'	'	2,821,889	'	'	'
Offerings costs	-125,981	'	'	-125,981	'	'
Net Income (Loss)	-6,318,724	'	'	'	'	-6,318,722
Balance at Dec. 31, 2013	$7,635,020	$1,000	$23,259	$26,163,522	'	($18,552,761)
Balance, shares at Dec. 31, 2013	'	1,000,000	23,259,109	'	'	'

Audited_Statement_of_Cash_Flow

Audited Statement of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows from Operations	'	'
Net Income (Loss)	($6,318,724)	($7,136,942)
Adjustments to reconcile net loss to cash used in operating activities:	'	'
Depreciation and amortization	484,907	452,231
Stock compensation	1,465,888	2,053,090
Revaluation of Assets	922,754	'
Gain on Settlement	-43,750	'
Deferred income taxes	'	456,500
Changes in operating assets:	'	'
Accounts receivable	-6,723	-100,158
Inventory	-64,088	-304,992
Prepaid and other current assets	2,793	-104,100
Security deposits	-6,417	-2,151
Accounts payable	-252,681	207,178
Accrued expenses	245,723	-43,893
Deferred revenue and customer deposits	-53,991	-93,332
Total adjustments to net income	2,694,415	2,520,373
Net cash (used in) operating activities	-3,624,309	-4,616,569
Cash Flows from Investing Activities	'	'
Acquisition of property, plant & equipment	-15,404	-5,035,750
Net cash flows (used in) investing activities	-15,404	-5,035,750
Cash Flows from Financing Activities	'	'
Advance from affiliate	'	-13,400
Advances from related party	'	-210,500
Proceeds from issuance of common stock	2,385,594	9,917,449
Net cash flows provided by (used in) financing activities	2,385,594	9,693,549
Net increase (decrease) in cash	-1,254,119	41,230
Cash balance, beginning	1,470,642	1,429,412
Cash balance, ending	216,523	1,470,642
Supplemental disclosure of cash flow information and non cash investing and financing activities:	'	'
Interest paid	1,269	2,813
Taxes paid	'	'
Non-cash transaction:	'	'
Capitalized construction cost for units placed in service	$549,772	$2,955,509

Background_Information

Background Information	12 Months Ended
	Dec. 31, 2013
Background Information [Abstract]	'
Background Information	'
	1.         Background Information
	MagneGas Corporation (the “Company”) was organized in the state of Delaware on December 9, 2005. The Company was originally organized under the name 4307, Inc, for the purpose of locating and negotiating with a business entity for a combination. On April 2, 2007 all the issued and outstanding shares of 4307, Inc. were purchased and the Company name was changed to MagneGas Corporation.
	MagneGas Corporation is an alternative energy company that creates and produces hydrogen based alternative fuel through the gasification of carbon-rich liquids including certain liquids and liquid wastes. We have developed a process which transforms various types of liquid waste through a proprietary plasma arc machine. A byproduct of this process is to produce an alternative to natural gas currently sold in the metalworking market. We produce gas bottled in cylinders for the purpose of distribution to the metalworking market as an alternative to acetylene. Additionally, we market, for sale or licensure, our proprietary plasma arc technology. Through the course of our business development, we have established retail and wholesale platforms to sell our fuel for use in the metalworking and manufacturing industries. In 2010, we recognized our initial sale of a Plasma Arc Flow unit and are continuing efforts to sell or lease additional equipment to end users.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	2.         Summary of Significant Accounting Policies
	The significant accounting policies followed are:
	Basis of Presentation
	The Company prepares its financial statements in conformity with generally accepted accounting principles in the United States of America. These principals require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates.
	Use of Estimates
	The Company prepares its financial statements in conformity with generally accepted accounting principles in the United States of America. These principals require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates. The financial statements presented include estimates for patent life, recoverability of deferred tax assets and collections on our receivables.  Our estimates include consideration of the useful lives of our intellectual property, allocations to research and development costs and recognition of deferred tax assets.
	Variable Interest Entities
	The Company considers the consolidation of entities to which the usual condition (ownership of a majority voting interest) of consolidation does not apply, focusing on controlling financial interests that may be achieved through arrangements that do not involve voting interest.  If an enterprise holds a majority of the variable interests of an entity, it would be considered the primary beneficiary.  The primary beneficiary is generally required to consolidate assets, liabilities and non-controlling interests at fair value (or at historical cost if the entity is a related party) and subsequently account for the variable interest as if it were consolidated based on a majority voting interest.   The Company has investments in joint ventures that are in development of the MagneGas technology, however the Company is not identified as a primary beneficiary; therefore no consolidation is required and the investments are listed at their cost.
	Fair Value of Financial Instruments
	In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities.  The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 “Fair Value Measurements and Disclosures” (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:
	●	Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
	●	Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	●	Level 3 - Inputs that are both significant to the fair value measurement and unobservable.
	Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2013. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, accrued compensation and accrued expenses. The fair value of the Company’s notes payable is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value.
	The Company applied ASC 820 for all non-financial assets and liabilities measured at fair value on a non-recurring basis. The adoption of ASC 820 for non-financial assets and liabilities did not have a significant impact on the Company’s financial statements.
	Cash and Cash Equivalents
	The majority of cash is maintained with a major financial institution in the United States.  Deposits with this bank may exceed the amount of insurance provided on such deposits.  At December 31, 2013, nothing exceeded the Federal Deposit Insurance Corporation (FDIC) limits. Generally, these deposits may be redeemed on demand and, therefore, bear minimal risk.  The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
	Accounts Receivable, Credit
	Accounts receivable consist of amounts due for the delivery of MagneGas sales to customers.    An allowance for doubtful accounts is considered to be established for any amounts that may not be recoverable, which is based on an analysis of the Company’s customer credit worthiness, and current economic trends.  Based on management’s review of accounts receivable, allowances for doubtful accounts were established as deemed necessary.   Receivables are determined to be past due, based on payment terms of original invoices.  Reserves for uncollectible accounts were $83,069 for 2013 as compared to $61,792 in 2012. The Company does not typically charge interest on past due receivables.
	Revenue Recognition
	The Company generates revenue through two processes: (1) Sale of MagneGas fuel for metal cutting and (2) Sale of its Plasma Arc Flow units.  Additionally we also recognize revenue from territorial license arrangements.
	●	Revenue for metalworking fuel is recognized when shipments are made to customers. The Company recognizes a sale when the product has been shipped and risk of loss has passed to the customer.
	●	Revenue generated from sales of its production unit is recognized on a percentage of completion, based on the progress during manufacturing of the unit.  Our machine is a significant investment and generally requires a 6 to 9 month production cycle.  During the course of building a unit the actual costs are tracked to our cost estimates and revenue is proportionately recognized during the process.   Significant deposits are required before production.  These deposits are classified as customer deposits.
	●	Licenses are issued, per contractual agreement, for distribution rights within certain geographic territories.  We recognize revenue ratably, based on the amounts paid or values received, over the term of the licensing agreement.
	Inventories
	Inventories are stated at the lower of standard cost or market, which approximates actual cost. Cost is determined using the first-in, first-out method.  Inventory is comprised of filled cylinders of MagneGas and accessories (regulators and tips) available for sale and accumulated costs incurred in the manufacturing process of units held for future sales.
	The Company is manufacturing additional units for sale.  Each unit is assigned a project number and the costs, including labor, are accumulated in the carrying value as inventory.  Upon delivery, the accumulated cost for the unit will be charged to cost of sales.  Units are reclassified to capitalized assets when shipped to location for the production of metal cutting gas for the purpose of resale.
	Long-Lived Assets
	Property and equipment is stated at cost.  Depreciation is computed by the straight-line method over estimated useful lives (3-7 years).  Intellectual property assets are stated at their fair value acquisition cost. Amortization of intellectual property assets is calculated by the straight line method over their estimated useful lives (15 years).  Historical costs are reviewed and evaluated for their net realizable value of the assets.  The carrying amount of all long-lived assets is evaluated periodically to determine if adjustment to the depreciation and amortization period or the unamortized balance is warranted. Based upon its most recent analysis, the Company believes that no impairment of property and equipment existed at December 31, 2013.
	Long-lived assets such as property, equipment and identifiable intangibles are reviewed for impairment whenever facts and circumstances indicate that the carrying value may not be recoverable.  When required impairment losses on assets to be held and used are recognized based on the fair value of the asset.  The fair value is determined based on estimates of future cash flows, market value of similar assets, if available, or independent appraisals, if required.  If the carrying amount of the long-lived asset is not recoverable from its undiscounted cash flows, an impairment loss is recognized for the difference between the carrying amount and fair value of the asset.  When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risk associated with the recovery of the assets.  We did not recognize any impairment losses for any periods presented.
	Stock Based Compensation
	The Company issues restricted stock to consultants for various services Cost for these transactions are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.  The value of the common stock is measured at the earlier of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete.   The Company recognized consulting expenses and a corresponding increase to additional paid-in-capital related to stock issued for services.  Stock compensation for the periods presented were issued to consultants for past services provided, accordingly, all shares issued are fully vested, and there is no unrecognized compensation associated with these transactions.
	Shipping Costs
	The Company includes shipping costs and freight-in costs in cost of goods sold.  Total freight-in included in cost of goods sold expense was $36,304 and $62,467 for the years ended December 31, 2013 and 2012, respectively.
	Advertising Costs
	The costs of advertising are expensed as incurred.  Advertising expenses are included in the Company’s operating expenses.  Advertising expense was $116,260 and $102,901 for the years ended December 31, 2013 and 2012, respectively
	Research and Development
	The Company expenses research and development costs when incurred.  Research and development costs include engineering and laboratory testing of product and outputs.
	Income Taxes
	The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purpose, referred to as temporary differences. Deferred tax assets and liabilities at the end of each period are determined using the currently enacted tax rates applied to taxable income in the periods in which the deferred tax assets and liabilities are expected to be settled or realized.
	Earnings (Loss) Per Share
	Basic earnings (loss) per share calculations are determined by dividing net income (loss) by the weighted average number of shares outstanding during the year. Diluted earnings (loss) per share calculations are determined by dividing net income (loss) by the weighted average number of shares.  The Company has issued options to several investors, upon their purchase of shares.  Options, whose strike price is less than the current market value, are considered common stock equivalents and are included in dilutive earnings per share.
			December 31,
			2013			2012
	Net Income (Loss)		$	(6,318,724	)	$	(7,136,942
	Weighted Average Shares
	Common Stock			(.29	)		(.32	)
	Common stock equivalents (Options)			(.29	)*		(.32	)
	* Net loss for the period, at December 31, 2013, 6,909,121 options and other dilutive common stock equivalents were considered anti-dilutive.

Recently_Issued_Accounting_Pro

Recently Issued Accounting Pronouncements	12 Months Ended
	Dec. 31, 2013
Recently Issued Accounting Pronouncements [Abstract]	'
Recently Issued Accounting Pronouncements	'
	3.         Recently Issued Accounting Pronouncements
	The Company reviews new accounting standards as issued.  No new standards had any material effect on these financial statements.  The accounting pronouncements issued subsequent to the date of these financial statements that were considered significant by management were evaluated for the potential effect on these consolidated financial statements.  Management does not believe any of the subsequent pronouncements will have a material effect on these consolidated financial statements as presented and does not anticipate the need for any future restatement of these consolidated financial statements because of the retro-active application of any accounting pronouncements issued subsequent to December 31, 2011 through the date these financial statements were issued.

Inventory

Inventory	12 Months Ended
	Dec. 31, 2013
Inventory [Abstract]	'
Inventory	'
	4.         Inventory
	Inventory primarily consists of:
		December 31,
		2013		2012
	Metal cutting fuel	$	255,497		$	57,187
	Units for resale, Construction in process		1,454,569			904,797
		$	1,710,066		$	961,984

Long_Lived_Assets

Long Lived Assets	12 Months Ended
	Dec. 31, 2013
Long Lived Assets [Abstract]	'
Long Lived Assets	'
	5.         Long Lived Assets
	Property and equipment consists of:
		December 31,
		2013		2012
	Machinery and equipment	$	230,563	$	465,358
	Furniture and office equipment		52,115		49,884
	Transportation		211,908		220,336
	Production units & cylinders		3,935,020		5,388,423
	Land and buildings		1,517,672		1,517,672
			5,967,896		7,641,673
	Less accumulated depreciation		661,744		448,302
		$	5,306,152	$	7,193,371
	Depreciation of fixed assets was $436,440 and $403,764  for the years ended December 31, 2013 and 2012, respectively.
	Intellectual property:
	The Company owns intellectual property, which it is amortizing on a straight-line basis over the assets useful life.  The Company assesses fair market value for any impairment to the carrying values.  As of December 31, 2013 management concluded that there was no impairment to the intangible assets.
		December 31,
		2013		2012
	Intellectual property	$	731,270	$	727,000
	Less accumulated amortization		248,446		199,978
		$	482,824	$	527,022
	Future amortization through December 31,:
	2014	$	48,467
	2015		48,467
	2016		48,467
	2017		48,467
	2018		48,467
	2019 and thereafter		242,489
		$	482,824
	Amortization of the intangible assets was $48,468 and $48,467 for the years ended December 31, 2013 and 2012, respectively.
	Management periodically reviews the valuation of this asset for potential impairments.  Consideration of various risks to the valuation and potential impairment includes, but is not limited to:  (a) the technology’s acceptance in the marketplace and our ability to attain projected forecasts of revenue (discounted cash flow of projections); (b) competition of alternative solutions; and (c) federal and state laws which may prohibit the use of our production machinery as currently designed.   Management has not impaired this asset, to date, and does not anticipate any negative impact from known current business developments. Management continuously measures the marketplace, potential revenue developments and competitive developments in the scientific industry.

Investment_in_Joint_Ventures

Investment in Joint Ventures	12 Months Ended
	Dec. 31, 2013
Investment in Joint Ventures [Abstract]	'
Investment in Joint Ventures	'
	6.         Investment in Joint Ventures
	On June 25, 2010, the Company entered into agreement with a Belgium company, whereby 250,000 shares of MagneGas Corporation’s common stock and territorial license rights were exchanged for a 20% interest in MagneGas Europe.  The Company valued the investment in the Joint Venture at the fair market value of the shares issued ($23,750).   The Company does not have effective or beneficial control over the European entity and is to account for the investment under the Equity Method.  Current year activity for the joint venture was immaterial.
	On June 28, 2010, the Company entered into agreement with DDI Industries, a China company, in formation of MagneGas China.  The Company is to provide mechanical drawings (for complete construction), computer programs, license of patents (Greater China Region), trademarks, etc. of the Plasma Arc Flow Recyclers to the new entity in exchange for a $2 million investment in MagneGas Corporation (received as of September 30, 2011; subscription at a share price of $0.135 or 14,814,814 common shares) and 20% share in MagneGas China.  The Company’s investment has been valued at $466,660, a mutually agreed amount for the technology license.  The MagneGas China entity has been funded in cash for an amount which reflects the intellectual property’s value. The Company does not have effective or beneficial control over the China entity and is to account for the investment under the Cost Method.  Current year activity for the joint venture was immaterial.
	Our investments in joint ventures are considered as Level 3, as defined in FASB Accounting Standards Codification (ASC) 820 “ Fair Value Measurements and Disclosures ” (ASC 820), and management considers alternative methods for valuing these investments to determine if there would be impairment to the current carrying value, currently our cost basis.   As of December 31, 2011, management does not believe any impairment exists with regard to the investments in joint ventures.

Deferred_Revenue_and_Customer_

Deferred Revenue and Customer Deposits	12 Months Ended
	Dec. 31, 2013
Deferred Revenue and Customer Deposits [Abstract]	'
Deferred Revenue and Customer Deposits	'
	7.         Deferred Revenue and Customer Deposits
	The Company has received deposits on production units and fees for exclusive territorial license.  The Company has deferred the associated revenues until such time that production order is placed and produced (recognition under percentage of completion method) or through the passage of time (recognition over the life of the license term).
		December 31,		December 31,
		2013		2012
	Mexico territory license, non-refundable payment from a company for a six-month period ending February 28, 2011	$	150,000	$	150,000
	China territory license, exclusive 5 year license, expiring June 28, 2015		466,660		466,660
	Philippines, deposit on production unit		100,000		100,000
	Mexican down payment on equipment		100,000
	Installment Payments from Kazakhstan for equipment purchase		499,000
			1,315,660		716,660
	Portion recognized		1,136,321		483,330
	Deferred revenue and customer deposits	$	179,339	$	233,330
	The amount recognized as revenue under licensing arrangements was, $93,332 and $93,332 for years ended December 31, 2013 and 2012, respectively.

Income_Tax

Income Tax	12 Months Ended
	Dec. 31, 2013
Income Tax [Abstract]	'
Income Tax	'
	8.         Income Tax
	Provision (Benefit) for Income Taxes
	The Company has not recognized a provision for income tax benefit during the periods presented, due to the net operating losses incurred.  The Company may recognize benefits in future periods when management believes that any benefit will be recognized.
	Deferred Income Taxes
	Deferred income taxes are the result of timing differences between book and tax basis of certain assets and liabilities, timing of income and expense recognition of certain items and net operating loss carry-forwards.
	The Company assesses temporary differences resulting from different treatments of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are recorded in our balance sheets. The Company evaluates the reliability of its deferred tax assets and assesses the need for a valuation allowance on an ongoing basis. In evaluating its deferred tax assets, the Company considers whether it is more likely than not that the deferred income tax assets will be realized. The ultimate realization of deferred tax assets depends upon generating sufficient future taxable income prior to the expiration of the tax attributes.  In assessing the need for a valuation allowance the Company must project future levels of taxable income. This assessment requires significant judgment. The Company examined the evidence related to a recent history of tax losses, the economic conditions in which it operates recent organizational changes, its forecasts and projections.  The Company will continue to evaluate its deferred tax assets to determine whether any changes in circumstances could affect the realization of their future benefit.
	The Company had not previously recognized an income tax benefit for its operating losses generated since inception through December 31, 2009 based on uncertainties concerning its ability to generate taxable income in future periods of which, at the time, the realization could not be considered more likely than not.  Based on events subsequent to the balance sheet date, management has re-assessed the valuation allowance and the recognition of its deferred tax losses, however, based on the Company’s history of losses and other negative evidence resulting in the allowance, no income tax benefit will be recognized for prior periods.  The tax benefit for the prior periods, in the amount of $348,800, arising from operating losses as a start-up company and other temporary differences, has been off-set by an equal valuation allowance.
	The following is a schedule of the deferred tax assets and liabilities as of December 31, 2013 and December 31, 2012:
		December 31,			December 31,
		2013			2012
	Deferred Tax Assets
	Net Operating Loss Carry Forwards	$	-		$	456,500
	Valuation Allowance				$	(456,000	)
	Deferred Tax Liabilities
	Total Deferred Tax Assets (Liabilities)	$	-		$
	Net Deferred Tax Asset (Liabilities)	$	-		$	-
	For balance sheet presentation the Company nets its current deferred tax assets and liabilities and non-current deferred tax assets and liabilities.
	Under the Internal Revenue Code of 1986, as amended, these losses can be carried forward twenty years.  As of December 31, 2013 the Company has net operating loss carry forwards remaining from the following years:
		Net
		Operating		Year
	Year Generated	Loss		Expires
	2007-2013 approx	$	18,000,000		By 2033
	The adoption of provisions, required by Accounting Standard Codification (“ASC”) No. 740, did not result in any adjustments.
	The Company is currently open to audit under the statute of limitations by the Internal Revenue Service for the years ending December 31, 2008 through 2013. The Company state income tax returns are open to audit under the statute of limitations for the years ending December 31, 2006 through 2013.
	The Company recognizes interest and penalties related to income taxes in income tax expense. The Company had incurred no penalties and interest for the three months ended December 31, 2013 and December 31, 2012.

Equity

Equity

12 Months Ended

Dec. 31, 2013

Equity [Abstract]

'

Equity

'

9.         Equity

The Company has three classifications of stock:

Common stock includes 90,000,000 shares authorized at a par value of $0.001.

Our certificate of incorporation provides that we are authorized to issue up to 10,000,000 shares of preferred stock with a par value of $0.001 per share. Our board of directors has the authority, without further action by the stockholders, to issue from time to time the preferred stock in one or more series for such consideration and with such relative rights, privileges, preferences and restrictions that the board may determine. The preferences, powers, rights and restrictions of different series of preferred stock may differ with respect to dividend rates, amounts payable on liquidation, voting rights, conversion rights, redemption provisions, sinking fund provisions and purchase funds and other matters. The issuance of preferred stock could adversely affect the voting power or other rights of the holders of common stock.

Of the 10,000,000 shares authorized of Preferred stock at a par value of $0.001, 1,000,000 shares and 2,141.1328 shares of preferred stock have been designated and issued as Series A Preferred Stock and Series B Convertible Preferred Stock, respectively.

Series A Preferred Stock has liquidation and dividend rights over common stock, which is not in excess of its par value. The preferred stock has no conversion rights or mandatory redemption features. There have been 1,000,000 shares of Preferred Stock issued to an entity controlled by Dr. Ruggero Santilli, Ermanno Santilli, President and CEO, Luisa Ingargiola, CFO and Carla Santilli, Director. Ermanno Santilli and Luisa Ingargiola have no equity interest, only voting control. Each share of Preferred Stock is entitled to 100,000 votes.

Series B Preferred Stock has a liquidation preference equal to the stated value of each share of Series B Preferred Stock or $1,000 per share. The shares of Series B Preferred Stock do not have any voting rights other than if the Company seeks to alter or adversely affect the rights of the Series B Preferred Stock. Subject to certain ownership limitations as described below, shares of Series B Preferred Stock are convertible at any time at the option of the holder into shares of the Company’s common stock at a conversion price of $0.80 per share.  The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below $0.80. Subject to limited exceptions, holders of shares of Series B Preferred Stock will not have the right to convert any portion of their Preferred Stock if the holder, together with its affiliates, would beneficially own in excess of 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to its conversion.

The holders of common stock and the equivalent Series A Preferred Stock, voting together, shall appoint the members of the Board of the Directors. Each share of common stock is entitled to one vote.

Reverse Stock Split

On June 26, 2012 we effected a ten-for-one reverse split of common shares.  All share amounts have been retroactively adjusted to reflect the post-split shares

Common Stock Issuances

On June 1, 2011, the Company executed agreements for two private offerings of its common stock (each an “Offering”).  In connection with the Offerings, the Company entered into two securities purchase agreements (each a “Securities Purchase Agreement”) with DDI Industry International (Beijing) Co., Ltd (the “Investor”).  Pursuant to the first Securities Purchase Agreement, the Company issued an aggregate of 384,625 shares of its common stock (the “Shares”) to the Investor for a purchase price of $500,000, at $1.30 per share.  Pursuant to the second Securities Purchase Agreement, the Company issued an aggregate of 333,333 Shares to the Investor for a purchase price of $561,248, at $1.68 per share.  The Company has received the proceeds from both offerings. The second offering, in the amount of $561,248 was received in August 2011.

Prior to this Offering, the Company and the Investor did have a material relationship.  In June 2010, the Company entered into an agreement with the Investor to form a Chinese joint venture (“MagneGas China”).  Pursuant to the agreement, the Investor acquired exclusive MagneGas™ Technology and manufacturing rights for the Greater China Market.  The Investor also acquired 1,481,482 shares of the Company’s common stock at a purchase price of $2 million and purchased a 300Kw Plasma Arc Refinery at a purchase price of $1.855 million.  The Company owns 20% of the equity in MagneGas China and the Company’s former Chief Executive Officer, Dr. Ruggero Santilli, is a member of the board of directors. The Company is working with MagneGas China to replace Dr. Ruggero Santilli with Ermanno Santilli in this position. Pursuant to the agreement, the Company appointed Allen Feng, the Chief Executive Officer of the Investor, to its board of directors.

In October and November 2011, the Company entered into a definitive agreement with investors to sell in a private placement 1,966,250 shares of its common stock at a purchase price of $1.60 per unit, including warrants to purchase 1,966,250 shares of its common stock at an exercise price of $3.00, resulting in gross proceeds to the Company of $3.2 million, before deducting placement agent fees and other offering expenses. The warrants are exercisable at a price of $3.00 per share and expire five years from the initial closing date.  During the quarter ended September 30, 2012, 84,125 options were exercised at the  option price of $3.00, for proceeds of $252,375, included in proceeds from sale of stock in financing activities of the statement of cash flows.

In the quarter ended March 31, 2012 the Company entered into a definitive agreement with investors to sell in a private placement an aggregate 1,941,250 shares of its common stock and warrants to purchase 970,625 shares of its common stock at a purchase price of $2.00 per unit, resulting in gross proceeds to the Company of $3,882,500, before deducting placement agent fees and other offering expenses.  The warrants are exercisable at an exercise price of $4.00 per share and expire five years from the initial closing date. Pursuant to the terms of the definitive agreement, the Company conducted two closings with parties to the definitive agreement.  The initial closing occurred on March 29, 2012, for gross proceeds of $3,117,500 in exchange for 1,558,750 shares of common stock and warrants to purchase an additional 779,375 shares of common stock.  The second closing was completed on April 3, 2012 for gross proceeds of $765,000 in exchange for 382,500 shares of common stock and warrants for an additional 191,250 shares of common stock.  No warrants have been exercised during the nine month period ending September 30, 2013.

On August 16, 2012 the Company completed a public offering of 2,850,000 shares of common stock at a price to the public of $3.00 per share. Of the 2,850,000 shares of common stock, an aggregate 652,173 shares were offered by three stockholders of the Company.  In addition, the Company and the selling stockholders granted the underwriters a 45-day option to purchase up to an additional 427,500 shares of common stock solely to cover over-allotments, if any.  The Company used the net proceeds from the offering to further develop its products and operations, for working capital, and general corporate purposes.  The Company did not receive any of the proceeds from the sale of shares by the selling stockholders.  The offering resulted in the net issuance of 2,197,827 shares of common stock (2,850,000, less 652,173 common shares of the selling shareholders) for gross proceeds of $6,593,481 less offering and closing costs of $758,477, resulting in net proceeds of $5,835,004.

On June 5, 2013, the Company closed its previously-announced underwritten public offering of 2,728,139 shares of common stock, par value $0.001 per share, and 2,728,139 warrants to purchase 682,035 shares of common stock with an exercise price of $1.35 per share, which includes the full exercise of the over-allotment option by the underwriter to purchase an additional 355,844 shares of common stock and warrants to purchase 88,961 shares of common stock with an exercise price of $1.35, at a combined price to the public of $0.90, for gross proceeds to the company of $2,455,325. The Company intends to use the proceeds from the offering for working capital and general corporate purposes. Northland Securities, Inc. acted as underwriter for the offering.

On September 27, 2013, the company settled a dispute with GreenPlanet Aid C.V. of Mexico (GreenPlanet) to which GreenPlanet was requesting a refund of a non-refundable deposit and as settlement of this dispute the Company offered 93,750 shares of common stock. This resulted in a $43,750 gain which is recognized as Other Income.  This is an unrelated entity to Clear Sky Energy S.A. de C.V. of Mexico, who have a current active contract with the Company.

Throughout 2013, the company issued 394,606 shares of common stock as payments for services.

Options and Warrants

In the period ending March 31, 2011, the Company issued 50,000 warrants to a consultant with an exercise term of 5 years and a strike price of $1.50.  The Company calculated the value of these shares at $68,500, based on using Black Sholes model.  Assumptions used in the calculation were volatility of 151.7%, estimated life of 2.5 years, 0% forfeiture and risk free interest rate of 1.8%.  On June 28, 2012, these warrants were exercised on a cashless basis, resulting in the issuance of 37,500 common shares.

During 2011, the Company also issued options attached to the purchase of shares at a 1:1 ratio, resulting in the issuance of 2,079,563 options.  Value for these attached options was included in the original capitalized transactions.  These options are exercisable within 3 years at a price of $3.00 per share. During the quarter ended September 30, 2012, 84,125 options were exercised for proceeds of $252,375.

In the period ending March 31, 2012, the Company issued 60,000 options to a consultant with an exercise term of 5 years, vesting over a one year period, and a strike price of $1.50.  The Company calculated the value of these shares at $19,300, based on using Black Sholes model.  Assumptions used in the calculation were volatility of 31.6%, estimated life of 1.5 years, 0% forfeiture and risk free interest rate of 1.8%.  On June 28, 2012 these warrants were exercised on a cashless basis, resulting in the issuance of 37,500 common shares.

On March 31, 2012 the Company issued 2,910,000 options to executives, in connection with employment agreements, at an exercise price of $1.50, vesting over a 3 year period.   The Company calculated the value of these shares at $3,921,900, based on using Black-Sholes model.  Assumptions used in the calculation were: volatility of 31.6%; estimated life of 2.5 years; 0% forfeiture; and risk free interest rate of .39%.  The Company recognized stock-based compensation, on a straight-line basis over the ratable vesting period, in the amount of $1,465,888 for the year ended December 31, 2013.

During the nine month period ended September 30, 2012, in association with the private placement stated above, there were 1,067,687 warrants issued with the $3,882,500 raise.  These warrants are for a five year period with an exercise price of $4.00 per share.

During the nine month period ended September 30, 2013, in association with the public offering stated above, there were 770,996 warrants issued with the $2,455,325 raise. These warrants are for a 5 year period with an exercise price of $1.35 per share.

The following is a summary of outstanding options and warrants:

Weighted Average

Options

Options

Intrinsic

Exercise

Remaining

Outstanding

Vested

Value

Price

Term

Options, December 31, 2011

2,215,039

2,215,039

Granted

3,977,687

1,320,187

$

3.43

$

2.17

4.8 years

Exercised

(88,887

)

(88,887

)

Forfeited

(130,714

)

(130,714

)

2.3 years

31-Dec-12

5,973,125

3,315,625

Granted

1,485,996

Exercised

-

Forfeited

550,000

31-Dec-13

6,909,121

4,553,922

$

2.44

$

1.43

2.9 years

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	10.       Related Party Transactions
	In February 2008, we entered into a five-year consulting agreement with Dr. Santilli, whose knowledge and expertise of the technology is essential in the development of the MagneGas product. The terms of the consulting agreement consist of issuance of common stock (10,000 shares) and payment of $5,000 per month to Dr. Santilli, upon the determination by the board of directors of MagneGas Corporation of achieving adequate funding. The board of directors has since determined that Dr. Santilli’s consulting agreement would be replaced with an employment agreement with a monthly salary of$15,000 per month.  On April 30, 2013, Dr. Santilli resigned and payments ceased.
	Beginning in April 2008, we entered into a month-to-month lease, at a monthly rate of $2,500 per month for facilities to occupy approximately 3,000 square feet of a 6,000 square foot building and the use of certain equipment and utilities, as needed. In January 2011, the Company expanded to occupy 5,000 square feet of the building and as a result, the rent was increased to $4,000 per month. The facility allows for expansion needs. The lease is held by EcoPlus, Inc., a company that is effectively controlled by Dr. Santilli.
	On June, 25, 2010, we entered into an agreement to acquire a 20% ownership of MagneGas Europe (MagneGas Arc Applied Solutions, Belgium). In exchange, we issued to MagneGas Arc Applied Solutions 25,000 shares of common shares, which were valued at the fair market price at the date of grant, June 25, 2010, at $0.95 per share for an aggregate of $23,750.  Dr. Santilli and Ermanno Santilli are stockholders of MagneGas Arc Applied Solutions, and at the time of the agreement, Ermanno Santilli, our current Chief Executive Officer, was the Chief Executive Officer of MagneGas Arc Applied Solutions and Vice President of MagneGas Corporation.
	Employment Agreements
	On March 31, 2012 we entered into employment agreements with our key employees.  A summary of these agreements are as follows:
	Executive Title	Term*	Annual		Options***
			Salary**
	Dr. Ruggero Santilli,	31-Mar-14	$	180,000	37,500 vesting per quarter,
	Chairman and Chief Scientist (resigned April 30, 2013)				exercisable at $1.50
	Ermanno Santilli,		$	144,000	37,500 vesting per quarter,
	Chief Executive Officer	31-Mar-14			exercisable at $1.50
	Luisa Ingargiola,	31-Mar-14	$	120,000	25,000 vesting per quarter,
	Chief Financial Officer				exercisable at $1.50
	Scott Wainwright,	31-Mar-14	$	120,000	37,500 vesting per quarter,
	President (resigned June 9, 2013)				exercisable at $1.50
	Carla Santilli,	31-Mar-14	$	60,000	25,000 vesting per quarter,
	Director				exercisable at $1.50
	*        Term is extendable at mutual consent.
	**      Annual salaries also stipulate performance bonuses, to be determined and approved by Board of Directors.
	***   Options, valued to be $3,921,900, using Black-Scholes method, The Company recognizes stock-based compensation, on a straight-line basis over the ratable vesting period.  Assumptions used in the calculation were: volatility of 31.6%; estimated life of 2.5 years; 0% forfeiture; and risk free interest rate of .39%.  The Company recognized stock based compensation in the amount of $1,039,500 for the year ending December 31, 2012.
	Director Compensation
	The three MagneGas independent board members receive $20,000 each in quarterly compensation for their services rendered on the Board of Directors. For 2012, this compensation was paid in the form of common stock equivalent shares, calculated based on the average common share price during the last 10 business days of each calendar quarter. Beginning in 2013, this compensation will be in the form of a combination of common stock and cash for services rendered.

Product_Line_Information

Product Line Information	12 Months Ended
	Dec. 31, 2013
Segment Information [Abstract]	'
Segment Information	'
	11.        Product Line   Information
	The following information is the results of our operating Product Line Revenues:
		Revenue		Costs		Margin
	31-Dec-12
	Segments:
	Unit Sales	$	-	$	-	$	-
	License Fees		93,332		-		93,332
	Metal Cutting		584,197		545,737		38,460
		$	677,529	$	545,737	$	131,792
	31-Dec-13
	Segments:
	Unit Sales	$	459,659	$	203,551	$	256,108
	License Fees		93,332		-		93,332
	Metal Cutting		435,995		344,927		91,068
		$	988,986	$	548,478	$	440,508

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2013
Contingencies [Abstract]	'
Contingencies	'
	12.       Contingencies
	From time to time the Company may be a party to litigation matters involving claims against the Company.  The Company operates with waste, hazardous material and within a highly regulated industry, which may lend itself to legal matters.  Management believes that there are no current matters that would have a material effect on the Company’s financial position or results of operations.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	13.       Subsequent events
	Stock Issuances
	On January 21, 2014, MagneGas Corporation (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”) providing for the issuance and sale by the Company (the “January 2014 Offering”) of  2,323,584 shares of the Company’s common stock, par value $0.001 per share, for a purchase price of $1,858,867 (the “Registered Stock”) and 2,141,133 million shares of the Company's Series B convertible preferred stock (the “Series B Preferred Stock”) which are convertible into a total of 2,676,416 shares of common stock (the “Conversion Shares”).  In connection with the purchase of shares of Series B Preferred Stock in the January 2014 Offering, the Investor will receive warrants to purchase a number of shares of common stock equal to 100% of the number of Conversion Shares at an exercise price equal to $1.11 (the “Warrants”).  Each Warrant shall be initially exercisable on the six (6) month anniversary of the issuance date and have a term of exercise equal to five (5) years from the date on which first exercisable.  The closing of the sale of these securities occurred on January 27, 2014.
	In February 2014 190,750 shares of common stock were granted to various consultants for services rendered for a total cost of $145,800.
	The Preferred Stock and the Warrants will be issued and sold without registration under the Securities Act of 1933, as amended, in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder and in reliance on similar exemptions under applicable state laws.  All potential investors in the January 2014 Offering, including the private placement, were solicited by means of direct contact by Northland Securities, Inc. (the “Placement Agent”). The Placement Agent had a substantive pre-existing relationship with the institutional investor and the Placement Agent and the Company did not engage in any form of general solicitation or general advertising (as those terms are used in Regulation D under the Securities Act) in connection with the offer or sale of the Series B Preferred Stock or the Warrants. Accordingly, the Investor may exercise those warrants and sell the underlying shares only pursuant to an effective registration statement under the Securities Act covering the resale of those shares, an exemption under Rule 144 under the Securities Act or another applicable exemption under the Securities Act.  Pursuant to a Registration Rights Agreement, dated January 21, 2014, by and between the Company and the Investor (the “Registration Rights Agreement”), the Company agreed to file one or more registration statements, this prospectus forms a part of the initial registration statement, with the SEC covering the resale of the shares of common stock issuable upon conversion of the Preferred Stock and upon exercise of the Warrants.
	Moreover, Northland Securities, Inc. acted as placement agent in connection with the January 2014 Offering and cash compensation equal to 7% of the total amount raised and received two warrants to purchase an aggregate amount of 250,001 shares of the Company’s common stock (“Agent Warrants”).
	On February 28, 2014, the Board of Directors approved an Option Plan for Employees for a total amount of 185,000 common shares at a strike price of $1.49 determined based on the terms of the Employee Incentive Plan.  The Options are a 5 year term, with a three year vesting cycle of 50% vesting in 12 months, 25% in 24 months and 25% in 36 months.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The Company prepares its financial statements in conformity with generally accepted accounting principles in the United States of America. These principals require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates..
Use of Estimates	'
	Use of Estimates
	The Company prepares its financial statements in conformity with generally accepted accounting principles in the United States of America. These principals require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates. The financial statements presented include estimates for patent life, recoverability of deferred tax assets and collections on our receivables.  Our estimates include consideration of the useful lives of our intellectual property, allocations to research and development costs and recognition of deferred tax assets.
Variable Interest Entities	'
	Variable Interest Entities
	The Company considers the consolidation of entities to which the usual condition (ownership of a majority voting interest) of consolidation does not apply, focusing on controlling financial interests that may be achieved through arrangements that do not involve voting interest.  If an enterprise holds a majority of the variable interests of an entity, it would be considered the primary beneficiary.  The primary beneficiary is generally required to consolidate assets, liabilities and non-controlling interests at fair value (or at historical cost if the entity is a related party) and subsequently account for the variable interest as if it were consolidated based on a majority voting interest.   The Company has investments in joint ventures that are in development of the MagneGas technology, however the Company is not identified as a primary beneficiary; therefore no consolidation is required and the investments are listed at their cost.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities.  The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 “ Fair Value Measurements and Disclosures ” (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:
	●	Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
	●	Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	●	Level 3 - Inputs that are both significant to the fair value measurement and unobservable.
	Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2013. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, accrued compensation and accrued expenses. The fair value of the Company’s notes payable is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value.
	The Company applied ASC 820 for all non-financial assets and liabilities measured at fair value on a non-recurring basis. The adoption of ASC 820 for non-financial assets and liabilities did not have a significant impact on the Company’s financial statements.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The majority of cash is maintained with a major financial institution in the United States.  Deposits with this bank may exceed the amount of insurance provided on such deposits.  At December 31, 2013, nothing exceeded the Federal Deposit Insurance Corporation (FDIC) limits. Generally, these deposits may be redeemed on demand and, therefore, bear minimal risk.  The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
Accounts Receivable, Credit	'
	Accounts Receivable, Credit
	Accounts receivable consist of amounts due for the delivery of MagneGas sales to customers.    An allowance for doubtful accounts is considered to be established for any amounts that may not be recoverable, which is based on an analysis of the Company’s customer credit worthiness, and current economic trends.  Based on management’s review of accounts receivable, allowances for doubtful accounts were established as deemed necessary.   Receivables are determined to be past due, based on payment terms of original invoices.  Reserves for uncollectible accounts were $83,069 for 2013 as compared to $61,792 in 2012. The Company does not typically charge interest on past due receivables.
Revenue Recognition	'
	Revenue Recognition
	The Company generates revenue through two processes: (1) Sale of MagneGas fuel for metal cutting and (2) Sale of its Plasma Arc Flow units.  Additionally we also recognize revenue from territorial license arrangements.
	●	Revenue for metalworking fuel is recognized when shipments are made to customers. The Company recognizes a sale when the product has been shipped and risk of loss has passed to the customer.
	●	Revenue generated from sales of its production unit is recognized on a percentage of completion, based on the progress during manufacturing of the unit.  Our machine is a significant investment and generally requires a 6 to 9 month production cycle.  During the course of building a unit the actual costs are tracked to our cost estimates and revenue is proportionately recognized during the process.   Significant deposits are required before production.  These deposits are classified as customer deposits.  .
	●	Licenses are issued, per contractual agreement, for distribution rights within certain geographic territories.  We recognize revenue ratably, based on the amounts paid or values received, over the term of the licensing agreement.
Inventories	'
	Inventories
	Inventories are stated at the lower of standard cost or market, which approximates actual cost. Cost is determined using the first-in, first-out method.  Inventory is comprised of filled cylinders of MagneGas and accessories (regulators and tips) available for sale and accumulated costs incurred in the manufacturing process of units held for future sales.
	The Company is manufacturing additional units for sale.  Each unit is assigned a project number and the costs, including labor, are accumulated in the carrying value as inventory.  Upon delivery, the accumulated cost for the unit will be charged to cost of sales.  Units are reclassified to capitalized assets when shipped to location for the production of metal cutting gas for the purpose of resale.
Long-Lived Assets	'
	Long-Lived Assets
	Property and equipment is stated at cost.  Depreciation is computed by the straight-line method over estimated useful lives (3-7 years).  Intellectual property assets are stated at their fair value acquisition cost. Amortization of intellectual property assets is calculated by the straight line method over their estimated useful lives (15 years).  Historical costs are reviewed and evaluated for their net realizable value of the assets.  The carrying amount of all long-lived assets is evaluated periodically to determine if adjustment to the depreciation and amortization period or the unamortized balance is warranted. Based upon its most recent analysis, the Company believes that no impairment of property and equipment existed at December 31, 2013.
	Long-lived assets such as property, equipment and identifiable intangibles are reviewed for impairment whenever facts and circumstances indicate that the carrying value may not be recoverable.  When required impairment losses on assets to be held and used are recognized based on the fair value of the asset.  The fair value is determined based on estimates of future cash flows, market value of similar assets, if available, or independent appraisals, if required.  If the carrying amount of the long-lived asset is not recoverable from its undiscounted cash flows, an impairment loss is recognized for the difference between the carrying amount and fair value of the asset.  When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risk associated with the recovery of the assets.  We did not recognize any impairment losses for any periods presented.
Stock Based Compensation	'
	Stock Based Compensation
	The Company issues restricted stock to consultants for various services Cost for these transactions are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.  The value of the common stock is measured at the earlier of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete.   The Company recognized consulting expenses and a corresponding increase to additional paid-in-capital related to stock issued for services.  Stock compensation for the periods presented were issued to consultants for past services provided, accordingly, all shares issued are fully vested, and there is no unrecognized compensation associated with these transactions.
Shipping Costs	'
	Shipping Costs
	The Company includes shipping costs and freight-in costs in cost of goods sold.  Total freight-in included in cost of goods sold expense was $36,304 and $62,467 for the years ended December 31, 2013 and 2012, respectively.
Advertising Costs	'
	Advertising Costs
	The costs of advertising are expensed as incurred.  Advertising expenses are included in the Company’s operating expenses.  Advertising expense was $116,260 and $102,901 for the years ended December 31, 2013 and 2012, respectively
Research and Development	'
	Research and Development
	The Company expenses research and development costs when incurred.  Research and development costs include engineering and laboratory testing of product and outputs.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purpose, referred to as temporary differences. Deferred tax assets and liabilities at the end of each period are determined using the currently enacted tax rates applied to taxable income in the periods in which the deferred tax assets and liabilities are expected to be settled or realized.
Earnings (Loss) Per Share	'
	Earnings (Loss) Per Share
	Basic earnings (loss) per share calculations are determined by dividing net income (loss) by the weighted average number of shares outstanding during the year. Diluted earnings (loss) per share calculations are determined by dividing net income (loss) by the weighted average number of shares.  The Company has issued options to several investors, upon their purchase of shares.  Options, whose strike price is less than the current market value, are considered common stock equivalents and are included in dilutive earnings per share.
			December 31,
			2013			2012
	Net Income (Loss)		$	(6,318,724	)	$	(7,136,942
	Weighted Average Shares
	Common Stock			(.29	)		(.32	)
	Common stock equivalents (Options)			(.29	)*		(.32	)
	* Net loss for the period, at December 31, 2013, 6,909,121 options and other dilutive common stock equivalents were considered anti-dilutive.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]	'
Summary of Dilutive earnings per share	'
		December 31,
			2013			2012
	Net Income (Loss)		$	(6,318,724	)	$	(7,136,942
	Weighted Average Shares
	Common Stock			(.29	)		(.32	)
	Common stock equivalents (Options)			(.29	)*		(.32	)
	* Net loss for the period, options and other dilutive common stock equivalents are anti-dilutive.

Inventory_Tables

Inventory (Tables)	12 Months Ended
	Dec. 31, 2013
Inventory [Abstract]	'
Summary of Inventory	'
		December 31,
		2013		2012
	Metal cutting fuel	$	255,497		$	57,187
	Units for resale, Construction in process		1,454,569			904,797
		$	1,710,066		$	961,984

Long_Lived_Assets_Tables

Long Lived Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Long Lived Assets [Abstract]	'
Summary of property, plant and equipment	'
		December 31,
		2013		2012
	Machinery and equipment	$	230,563	$	465,358
	Furniture and office equipment		52,115		49,884
	Transportation		211,908		220,336
	Production units & cylinders		3,935,020		5,388,423
	Land and buildings		1,517,672		1,517,672
			5,967,896		7,641,673
	Less accumulated depreciation		661,744		448,302
		$	5,306,152	$	7,193,371
Schedule of carrying value of Intellectual property	'
		December 31,
		2013		2012
	Intellectual property	$	731,270	$	727,000
	Less accumulated amortization		248,446		199,978
		$	482,824	$	527,022
Summary of Future amortization expenses of Intellectual property	'
	Future amortization through December 31,:
	2014	$	48,467
	2015		48,467
	2016		48,467
	2017		48,467
	2018		48,467
	2019 and thereafter		242,489
		$	482,824

Deferred_Revenue_and_Customer_1

Deferred Revenue and Customer Deposits (Tables)	12 Months Ended
	Dec. 31, 2013
Deferred Revenue and Customer Deposits [Abstract]	'
Summary of Deferred revenue and customer deposits	'
		December 31,		December 31,
		2013		2012
	Mexico territory license, non-refundable payment from a company for a six-month period ending February 28, 2011	$	150,000	$	150,000
	China territory license, exclusive 5 year license, expiring June 28, 2015		466,660		466,660
	Philippines, deposit on production unit		100,000		100,000
	Mexican down payment on equipment		100,000
	Installment Payments from Kazakhstan for equipment purchase		499,000
			1,315,660		716,660
	Portion recognized		1,136,321		483,330
	Deferred revenue and customer deposits	$	179,339	$	233,330

Income_Tax_Tables

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax [Abstract]	'
Schedule of deferred tax assets and liabilities	'
		December 31,			December 31,
			2013			2012
	Deferred Tax Assets
	Net Operating Loss Carry Forwards		$	-		$	456,500
	Valuation Allowance					$	(456,000	)
	Deferred Tax Liabilities
	Total Deferred Tax Assets (Liabilities)		$	-		$
	Net Deferred Tax Asset (Liabilities)		$	-		$	-
Summary of operating loss carryforwards	'
	Net
			Operating		Year
	Year Generated		Loss		Expires
	2007-2013 approx		$	18,000,000		By 2033

Equity_Tables

Equity (Tables)	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Summary of outstanding options and warrants	'
					Weighted Average
		Options			Options			Intrinsic		Exercise		Remaining
		Outstanding			Vested			Value		Price		Term
	Options, December 31, 2011		2,215,039			2,215,039
	Granted		3,977,687			1,320,187		$	3.43	$	2.17	4.8 years
	Exercised		(88,887	)		(88,887	)
	Forfeited		(130,714	)		(130,714	)					2.3 years
	31-Dec-12		5,973,125			3,315,625
	Granted		1,485,996
	Exercised		-
	Forfeited		550,000
	31-Dec-13		6,909,121			4,553,922		$	2.44	$	1.43	2.9 years

Related_Party_Transactions_Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Summary of employment agreement with related parties	'
	Executive Title	Term*	Annual		Options***
			Salary**
	Dr. Ruggero Santilli,	31-Mar-14	$	180,000	37,500 vesting per quarter,
	Chairman and Chief Scientist (resigned April 30, 2013)				exercisable at $1.50
	Ermanno Santilli,		$	144,000	37,500 vesting per quarter,
	Chief Executive Officer	31-Mar-14			exercisable at $1.50
	Luisa Ingargiola,	31-Mar-14	$	120,000	25,000 vesting per quarter,
	Chief Financial Officer				exercisable at $1.50
	Scott Wainwright,	31-Mar-14	$	120,000	37,500 vesting per quarter,
	President (resigned June 9, 2013)				exercisable at $1.50
	Carla Santilli,	31-Mar-14	$	60,000	25,000 vesting per quarter,
	Director				exercisable at $1.50
	*        Term is extendable at mutual consent.
	**      Annual salaries also stipulate performance bonuses, to be determined and approved by Board of Directors.
	***   Options, valued to be $3,921,900, using Black-Scholes method, The Company recognizes stock-based compensation, on a straight-line basis over the ratable vesting period.  Assumptions used in the calculation were: volatility of 31.6%; estimated life of 2.5 years; 0% forfeiture; and risk free interest rate of .39%.  The Company recognized stock based compensation in the amount of $1,039,500 for the year ending December 31, 2012.

Product_Line_Information_Table

Product Line Information (Tables)	12 Months Ended
	Dec. 31, 2013
Segment Information [Abstract]	'
Schedule of operating revenue segments	'
		Revenue		Costs		Margin
	31-Dec-12
	Segments:
	Unit Sales	$	-	$	-	$	-
	License Fees		93,332		-		93,332
	Metal Cutting		584,197		545,737		38,460
		$	677,529	$	545,737	$	131,792
	31-Dec-13
	Segments:
	Unit Sales	$	459,659	$	203,551	$	256,108
	License Fees		93,332		-		93,332
	Metal Cutting		435,995		344,927		91,068
		$	988,986	$	548,478	$	440,508

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012
Summary of Dilutive earnings per share	'		'
Net loss	($6,318,724)		($7,136,942)
Weighted Average Shares	'		'
Weighted Average Per Share, Diluted	($0.29)		($0.32)
Common Stock [Member]	'		'
Weighted Average Shares	'		'
Weighted Average Per Share, Diluted	($0.29)		($0.32)
Common stock equivalents (Options) [Member]	'		'
Weighted Average Shares	'		'
Weighted Average Per Share, Diluted	($0.29)	[1]	($0.32)
[1]	Net loss for the period, options and other dilutive common stock equivalents are anti-dilutive.

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Summary of Significant Accounting Policies (Textual)	'	'
Specific life for intellectual property	'15 years	'
Shipping Costs	$36,304	$62,467
Advertising expense	116,260	102,901
Reserves for uncollectible accounts	$83,069	$61,792
Options and other dilutive common stock equivalents	6,909,121	'
Minimum [Member]	'	'
Summary of Significant Accounting Policies (Textual)	'	'
Production cycle of the machine	'6 months	'
Estimated useful lives	'3 years	'
Maximum [Member]	'	'
Summary of Significant Accounting Policies (Textual)	'	'
Production cycle of the machine	'9 months	'
Estimated useful lives	'7 years	'

Inventory_Details

Inventory (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Summary of Inventory	'	'
Metal cutting fuel	$255,497	$57,187
Units for resale, Construction in process	1,454,569	904,797
Total inventory	$1,710,066	$961,984

Long_Lived_Assets_Details

Long Lived Assets (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Summary of property, plant and equipment	'	'
Property and equipment, Gross	$5,967,896	$7,641,673
Less accumulated depreciation	661,744	448,302
Property and equipment, Net	5,306,152	7,193,371
Machinery and equipment [Member]	'	'
Summary of property, plant and equipment	'	'
Property and equipment, Gross	230,563	465,358
Furniture and office equipment [Member]	'	'
Summary of property, plant and equipment	'	'
Property and equipment, Gross	52,115	49,884
Transportation [Member]	'	'
Summary of property, plant and equipment	'	'
Property and equipment, Gross	211,908	220,336
Production units & cylinders [Member]	'	'
Summary of property, plant and equipment	'	'
Property and equipment, Gross	3,935,020	5,388,423
Land and buildings [Member]	'	'
Summary of property, plant and equipment	'	'
Property and equipment, Gross	$1,517,672	$1,517,672

Long_Lived_Assets_Details_1

Long Lived Assets (Details 1) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Schedule of carrying value of Intellectual property	'	'
Intellectual property	$731,270	$727,000
Less accumulated amortization	248,446	199,978
Intellectual property, Net	$482,824	$527,022

Long_Lived_Assets_Details_2

Long Lived Assets (Details 2) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Future amortization through December 31,:	'	'
2014	$48,467	'
2015	48,467	'
2016	48,467	'
2017	48,467	'
2018	48,467	'
2019 and thereafter	242,489	'
Intellectual property, Net	$482,824	$527,022

Long_Lived_Assets_Details_Text

Long Lived Assets (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Long Lived Assets (Textual)	'	'
Depreciation of equipment	$436,440	$403,764
Amortization of intangible assets	$48,468	$48,467

Investment_in_Joint_Ventures_D

Investment in Joint Ventures (Details) (USD $)	Aug. 31, 2012	Jun. 28, 2010	Jun. 25, 2010
Investment in Joint Ventures (Textual)	'	'	'
MagneGas Corporation's common stock exchanged to purchase the interest in MagneGas Europe	'	'	250,000
Interest purchased in MagneGas Europe	'	'	20.00%
Company valued the investment in the Joint Venture at the fair market value of the shares issued	'	'	($23,750)
Agreement's exchange price given to DDI industries	'	2,000,000	'
Share price of subscription	$3	$0.14	'
Number of common shares given for subscription	'	14,814,814	'
Share of subsidiary given to party in addition to agreement exchange price	'	20.00%	'
Company's investment for technology license	'	$466,660	'

Deferred_Revenue_and_Customer_2

Deferred Revenue and Customer Deposits (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Summary of deferred revenue and customer deposits	'	'
Deferred revenue and customer deposits, Gross	$1,315,660	$716,660
Portion recognized	1,136,321	483,330
Deferred revenue and customer deposits, Net	179,339	233,330
Mexico territory license, non-refundable payment from a company for a six-month period ending February 28, 2011 [Member]	'	'
Summary of deferred revenue and customer deposits	'	'
Deferred revenue and customer deposits, Gross	150,000	150,000
China territory license, exclusive 5 year license, expiring June 28, 2015 [Member]	'	'
Summary of deferred revenue and customer deposits	'	'
Deferred revenue and customer deposits, Gross	466,660	466,660
Philippines, deposit on production unit [Member]	'	'
Summary of deferred revenue and customer deposits	'	'
Deferred revenue and customer deposits, Gross	100,000	100,000
Mexican down payment on equipment [Member]	'	'
Summary of deferred revenue and customer deposits	'	'
Deferred revenue and customer deposits, Gross	100,000	'
Installment Payments from Kazakhstan for equipment purchase [Member]	'	'
Summary of deferred revenue and customer deposits	'	'
Deferred revenue and customer deposits, Gross	$499,000	'

Deferred_Revenue_and_Customer_3

Deferred Revenue and Customer Deposits (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Deferred Revenue and Customer Deposits (Textual)	'	'
China territory license period	'5 years	'
China territory license, Expiration Date	28-Jun-15	'
License Fees, Revenue	$93,332	$93,332

Income_Tax_Details

Income Tax (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred Tax Assets	'	'
Net Operating Loss Carry Forwards	'	$456,500
Valuation Allowance	'	-456,500
Deferred Tax Liabilities	'	'
Total Deferred Tax Assets (Liabilities)	'	'
Net Deferred Tax Asset (Liabilities)	'	'

Income_Tax_Details_1

Income Tax (Details 1) (2007-2013 approx [Member], USD $)	12 Months Ended
	Dec. 31, 2013
2007-2013 approx [Member]	'
Summary of net operating loss carry forwards	'
Net Operating Loss	$18,000,000
Year Expires	'By 2033

Income_Tax_Details_Textual

Income Tax (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013
Income Tax (Textual)	'
Income tax expense benefit for prior periods	$348,800

Equity_Details

Equity (Details) (USD $)	3 Months Ended		12 Months Ended
	Sep. 30, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
			Option and Warrant [Member]	Option and Warrant [Member]
Summary of outstanding options and warrants	'	'	'	'
Options and warrants Outstanding, Beginning Balance	'	6,909,121	5,973,125	2,215,039
Options and warrants Outstanding, Granted	'	'	1,485,996	3,977,687
Options and warrants Outstanding, Exercised	84,125	'	'	-88,887
Options and warrants Outstanding, Forfeited	'	'	550,000	-130,714
Options and warrants Outstanding, Ending Balance	'	6,909,121	6,909,121	5,973,125
Options and warrants Vested, Beginning Balance	'	'	3,315,625	2,215,039
Options and warrants vested, Granted	'	'	'	1,320,187
Options and warrants Vested, Exercised	'	'	'	-88,887
Options and warrants vested, Forfeited	'	'	'	-130,714
Options and warrants Vested, Ending Balance	'	'	4,553,922	3,315,625
Options and warrants granted, weighted average Intrinsic value	'	'	'	$3.43
Options and warrants outstanding, weighted average Intrinsic value	'	'	$2.44	'
Options and warrants granted, weighted average exercise Price	'	'	'	$2.17
Options and warrants outstanding, weighted average exercise Price	'	'	$1.43	'
Weighted Average Remaining Term, Options and warrants granted	'	'	'	'4 years 9 months 18 days
Options and warrants outstanding, weighted average Remaining term	'	'	'2 years 10 months 24 days	'2 years 3 months 18 days

Equity_Details_Textual

Equity (Details Textual) (USD $)

0 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

Jun. 05, 2013

Aug. 31, 2012

Jun. 26, 2012

Mar. 31, 2012

Jun. 30, 2010

Sep. 30, 2012

Mar. 31, 2012

Mar. 31, 2011

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Jun. 28, 2012

Apr. 03, 2012

Mar. 29, 2012

Jun. 01, 2011

Jun. 28, 2010

Jun. 01, 2011

Jun. 01, 2011

Nov. 30, 2011

Mar. 31, 2012

Jan. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Sep. 27, 2013

Dec. 31, 2013

Dec. 31, 2013

Stockholders

Stockholders

First securities purchase agreement [Member]

Second securities purchase agreement [Member]

Definitive Agreement [Member]

Definitive Agreement [Member]

Controller and other board of directors [Member]

Common Stock [Member]

Common Stock [Member]

Green Planet [Member]

Series A Preferred Stock [Member]

Series B Preferred Stock [Member]

Equity (Textual)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock value

'

'

'

'

'

'

'

'

'

'

$1,000

$1,000

'

'

'

'

'

'

'

'

'

'

$998

'

'

'

'

'

Shares issued under securities purchase agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

384,625

333,333

'

'

'

'

'

'

'

'

Shares issued under securities purchase agreement value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

500,000

561,248

'

'

'

'

'

'

'

'

Share price

'

$3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.14

$1.30

$1.68

'

'

'

'

'

'

'

'

Options and warrants Outstanding, Exercised

'

'

'

'

'

84,125

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from issuance of stock under private placement

'

'

'

'

'

252,375

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,200,000

3,882,500

'

'

'

'

'

'

Common stock and warrants sold under private placement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,966,250

1,941,250

'

'

'

'

'

'

Repurchase of common stock under private placement

'

'

'

'

'

'

'

'

'

'

'

'

2,079,563

'

'

'

'

'

'

'

1,966,250

970,625

'

'

'

'

'

'

Repurchase price of common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.60

$2

'

'

'

'

'

'

Proceeds in exchange of common stock and warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,117,500

'

'

'

'

'

'

'

'

'

'

'

'

Exchange of common stock and warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

37,500

'

1,558,750

'

'

'

'

'

'

'

'

'

'

'

'

Purchase of additional common stock due to exchange of common stock and warrant

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

779,375

'

'

'

'

'

'

'

'

'

'

'

'

Subscription receivable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

765,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Common shares and warrants subscribed

2,728,139

'

'

'

'

'

'

'

'

'

'

'

'

'

382,500

'

'

'

'

'

'

'

'

'

'

'

'

'

Subscription of additional common share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

191,250

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants expiration term

'

'

'

'

'

'

'5 years

'

'5 years

'5 years

'

'

'3 years

'

'

'

'

'

'

'

'5 years

'5 years

'

'

'

'

'

'

Warrants exercise price

$1.35

'

'

'

'

'

'

'

$1.35

$4

'

'

$3

'

'

'

'

'

'

'

$3

$4

'

'

'

'

'

'

Equity (Additional Textual)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, shares authorized

'

'

'

'

'

'

'

'

'

'

10,000,000

10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, par value

'

'

'

'

'

'

'

'

'

'

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, shares issued

'

'

'

'

'

'

'

'

'

'

1,000,000

1,000,000

'

'

'

'

'

'

'

'

'

'

998,000

'

'

'

1,000,000

21,411,328

Preferred stock, voting rights

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Each share of Preferred Stock is entitled to 100,000 votes.

'The shares of Series B Preferred Stock do not have any voting rights other than if the Company seeks to alter or adversely affect the rights of the Series B Preferred Stock.

Common stock, shares authorized

'

'

'

'

'

'

'

'

'

'

90,000,000

90,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, liquidation preference per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,000

Terms of conversion, Preferred stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'The conversion price is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions and any issuances of securities below $0.80. Subject to limited exceptions, holders of shares of Series B Preferred Stock will not have the right to convert any portion of their Preferred Stock if the holder, together with its affiliates, would beneficially own in excess of 4.99% of the number of shares of the Company's common stock outstanding immediately after giving effect to its conversion.

Common stock, par value

'

'

'

'

'

'

'

'

'

'

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of private offering

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

Number of securities purchase agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

Common stock acquired in joint venture

'

'

'

'

1,481,482

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock value acquired in joint venture

'

'

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Units of Plasma arc purchased in (Kw)

'

'

'

'

'300

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Value of refinery

'

'

'

'

1,855,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Joint venture ownership percentage

'

'

'

'

20.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrant issued

'

'

'

'

'

'

'

50,000

770,996

1,067,687

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from issuance of warrants

'

'

'

'

'

'

'

'

2,455,325

3,882,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options attached to purchase of shares, ratios

'

'

'

'

'

'

'

'

'

'

'

'

'1:1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Calculated value of warrants using Black Sholes model

'

'

'

3,921,900

'

'

3,921,900

68,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expected volatility rate assumed under Black Sholes model

'

'

'

'

'

'

'

151.70%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expected term assumed under Black Sholes model

'

'

'

'

'

'

'

'2 years 6 months

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expected percentage of forfeiture assumed under Black Sholes model

'

'

'

'

'

'

'

0.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Risk free interest rate assumed under Black Sholes model

'

'

'

'

'

'

'

1.80%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of options issued

'

'

'

2,910,000

'

'

60,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expected life of options

'

'

'

'2 years 6 months

'

'

'1 year 6 months

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options issued, vesting period

'

'

'

'3 years

'

'

'1 year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reverse stock split of common shares

'

'

'Ten-for-one

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options issued, strike price

'

'

'

$1.50

'

'

$1.50

$1.50

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options, Outstanding, Intrinsic Value

'

'

'

19,300

'

'

19,300

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Volatility rate

'

'

'

31.60%

'

'

31.60%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Forfeiture rate

'

'

'

0.00%

'

'

0.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Risk free interest rate

'

'

'

0.39%

'

'

1.80%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options exercise price

'

'

'

'

'

$3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Recognized stock-based compensation

'

'

'

'

'

'

'

'

'

'

1,465,888

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common shares issued: (Shares)

'

2,850,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,821,889

'

93,750

'

'

Number of stockholders offered shares to public

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of days granted to underwriters for purchase of additional shares

'

'45 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of additional shares purchased to cover over allotment by underwriters

355,844

427,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net proceeds from issuance of common stock

'

2,197,827

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from issuance of common stock

2,455,325

6,593,481

'

'

'

'

'

'

'

'

2,385,594

9,917,449

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Offering cost of common stock

'

758,477

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net proceeds from issuance of common stock net of issuance cost

'

5,835,004

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock offered to public

'

652,173

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Per share price of common stock offered to public

'

$3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of warrants to purchase common stock

88,961

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares issue on exercise of warrants

682,035

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Combine exercise price

$0.90

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other Income

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$43,750

'

'

Stock Issued During Period, Shares, Issued for Services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

394,606

334,220

'

'

'

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	3 Months Ended
	Mar. 31, 2012
Dr. Ruggero Santilli, Chairman and Chief Scientist [Member]	'
Summary of employment agreement with related parties	'
Term of related parties	31-Mar-14	[1]
Annual salary payable to related parties	$180,000	[2]
Options available to related parties	'37,500 vesting per quarter, exercisable at $1.50	[3]
Ermanno Santilli, Chief Executive Officer [Member]	'
Summary of employment agreement with related parties	'
Term of related parties	31-Mar-14	[1]
Annual salary payable to related parties	144,000	[2]
Options available to related parties	'37,500 vesting per quarter, exercisable at $1.50	[3]
Luisa Ingargiola, Chief Financial Officer [Member]	'
Summary of employment agreement with related parties	'
Term of related parties	31-Mar-14	[1]
Annual salary payable to related parties	120,000	[2]
Options available to related parties	'25,000 vesting per quarter, exercisable at $1.50	[3]
Scott Wainright, President [Member]	'
Summary of employment agreement with related parties	'
Term of related parties	31-Mar-14	[1]
Annual salary payable to related parties	120,000	[2]
Options available to related parties	'37,500 vesting per quarter , exercisable at $1.50	[3]
Carla Santilli, Director [Member]	'
Summary of employment agreement with related parties	'
Term of related parties	31-Mar-14	[1]
Annual salary payable to related parties	$60,000	[2]
Options available to related parties	'25,000 vesting per quarter, exercisable at $1.50	[3]
[1]	Term is extendable at mutual consent.
[2]	Annual salaries also stipulate performance bonuses, to be determined and approved by Board of Directors.
[3]	Options, valued to be $3,921,900, using Black-Scholes method, The Company recognizes stock-based compensation, on a straight-line basis over the ratable vesting period. Assumptions used in the calculation were: volatility of 31.6%; estimated life of 2.5 years; 0% forfeiture; and risk free interest rate of .39%. The Company recognized stock based compensation in the amount of $1,039,500 for the year ending December 31, 2012.

Related_Party_Transactions_Det1

Related Party Transactions (Details Textual) (USD $)	1 Months Ended				3 Months Ended		12 Months Ended		1 Months Ended	12 Months Ended	1 Months Ended
	Mar. 31, 2012	Jan. 31, 2011	Jun. 25, 2010	Apr. 30, 2008	Mar. 31, 2012	Mar. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2012	Feb. 29, 2008
		Squarefeets		Squarefeets					Stock Options [Member]	Stock Options [Member]	Dr. Ruggero Santilli, Chairman and Chief Scientist [Member]
Related Party Transactions (Textual)	'	'	'	'	'	'	'	'	'	'	'
Period of consulting agreement	'	'	'	'	'	'	'	'	'	'	'5 years
Issuance of common stock	'	'	'	'	'	'	23,259,109	20,042,616	'	'	10,000
Monthly payment made to Dr. Santilli	'	'	'	'	'	'	'	'	'	'	$5,000
Replaced monthly salary of Dr. Santilli	'	'	'	'	'	'	'	'	'	'	15,000
Related party transaction monthly lease payments	'	'	'	2,500	'	'	'	'	'	'	'
Related party transaction occupy leased (Square feet)	'	'	'	3,000	'	'	'	'	'	'	'
Area of building (Square foot)	'	'	'	6,000	'	'	'	'	'	'	'
Options, Outstanding, Intrinsic Value	19,300	'	'	'	19,300	'	'	'	3,921,900	'	'
Volatility rate	31.60%	'	'	'	31.60%	'	'	'	31.60%	'	'
Expected life of options	'2 years 6 months	'	'	'	'1 year 6 months	'5 years	'	'	'2 years 6 months	'	'
Forfeiture rate	0.00%	'	'	'	0.00%	'	'	'	0.00%	'	'
Risk free interest rate	0.39%	'	'	'	1.80%	'	'	'	0.39%	'	'
Percentage of ownership acquired	'	'	20.00%	'	'	'	'	'	'	'	'
Common stock issue, value for acquiring ownership	'	'	23,750	'	'	'	'	'	'	'	'
Common stock issue, shares for acquiring ownership	'	'	25,000	'	'	'	'	'	'	'	'
Common stock , price per share	'	'	$0.95	'	'	'	'	'	'	'	'
Expended area to occupy leased (Square feet)	'	5,000	'	'	'	'	'	'	'	'	'
Increased amount of rent per month	'	4,000	'	'	'	'	'	'	'	'	'
Recognized Stock Based Compensation	'	'	'	'	'	'	1,465,888	'	'	1,039,500	'
Board members compensation	'	'	'	'	'	'	$20,000	'	'	'	'
Directors compensation methodology	'	'	'	'	'	'	'This compensation was paid in the form of common stock equivalent shares, calculated based on the average common share price during the last 10 business days of each calendar quarter.	'	'	'	'

Product_Line_Information_Detai

Product Line Information (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Schedule of operating revenue segments	'	'
Metal Cutting, Revenue	$435,995	$584,197
Metal Cutting, Costs	344,927	545,737
Metal Cutting, Margin	91,068	38,460
License Fees, Revenue	93,332	93,332
License Fees, Costs	'	'
License Fees, Margin	93,332	93,332
Unit Sales, Revenue	459,659	'
Unit Sales, Costs	203,551	'
Unit Sales, Margin	256,108	'
Revenue	988,986	677,529
Direct costs, metal cutting	548,478	545,737
Gross Profit	$440,508	$131,792

Subsequent_Events_Detail

Subsequent Events (Detail) (USD $)	1 Months Ended	12 Months Ended		1 Months Ended	12 Months Ended	1 Months Ended	12 Months Ended
	Aug. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Feb. 27, 2014	Dec. 31, 2013	Jan. 21, 2014	Dec. 31, 2013
				Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
						Securities Purchase Agreement [Member]	Northland Securities Inc [Member]
							Warrants
Subsequent Event [Line Items]	'	'	'	'	'	'	'
Common stock shares issued	2,850,000	'	'	'	'	2,323,584	250,001
Common stock, par value	'	$0.00	$0.00	'	'	$0.00	'
Common stock shares, value	'	$2,511,575	'	'	'	$1,858,867	'
Conversion of Stock, Shares	'	'	'	'	'	2,676,416	'
Conversion of Stock, Value	'	'	'	'	'	2,141,133	'
Conversion exercise price	'	'	'	'	'	$1.11	'
Common stock convertible percentage	'	'	'	'	'	100.00%	'
Warrants exercisable term	'	'	'	'	'	'Each Warrant shall be initially exercisable on the six (6) month anniversary of the issuance date and have a term of exercise equal to five (5) years from the date on which first exercisable.	'
Common stock issued for services, shares	'	'	'	190,750	'	'	'
Percentage of cash compensation	'	'	'	'	'	'	7.00%
Number of warrants received	'	'	'	'	'	'	2
Option plan for employees, Total amount	'	'	'	'	185,000	'	'
Common shares at a strike price	'	'	'	'	$1.49	'	'
Employees Stock Options Description	'	'	'	'	'The Options are a 5 year term, with a three year vesting cycle of 50% vesting in 12 months, 25% in 24 months and 25% in 36 months.	'	'
common stock consultants for services rendered total cost	'	$1,496,303	$989,324	$145,800	'	'	'